Combined inhibition of MEK and PI3K pathways overcomes acquired resistance to EGFR-TKIs in non-small cell lung cancer-Reference-Cited by-同舟云学术

Combined inhibition of MEK and PI3K pathways overcomes acquired resistance to EGFR-TKIs in non-small cell lung cancer

Published:2018-09-14 Issue:10 Volume:109 Page:3183-3196
ISSN:1347-9032
Container-title:Cancer Science
language:en
Short-container-title:Cancer Sci

Author:

Sato Hiroki¹,Yamamoto Hiromasa¹^ORCID,Sakaguchi Masakiyo²,Shien Kazuhiko¹,Tomida Shuta³,Shien Tadahiko¹,Ikeda Hirokuni¹,Hatono Minami¹,Torigoe Hidejiro¹,Namba Kei¹,Yoshioka Takahiro⁴,Kurihara Eisuke¹,Ogoshi Yusuke¹,Takahashi Yuta¹,Soh Junichi¹,Toyooka Shinichi¹⁴^ORCID

Affiliation:

1. Department of Thoracic, Breast and Endocrine Surgery; Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences; Okayama Japan

2. Department of Cell Biology; Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences; Okayama Japan

3. Department of Bioinformatics; Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences; Okayama Japan

4. Department of Clinical Genomic Medicine; Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences; Okayama Japan

Funder

Japan Society for the Promotion of Science

Publisher

Wiley

Subject

Cancer Research,Oncology,General Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/cas.13763/fullpdf

Reference46 articles.